The race to best treat a disease long confused with MS heats up with Roche's PhIII results
With inflamed myelin and frequent optic neuritis episodes, NMOSD patients were for years confused with MS patients. Now multiple treatments for the rare autoimmune disease …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
